Liver Contrast Agents

Watch alumna Dr. Gesine Knobloch’s award winning explanation of imaging with contrast agents in the liver.

Selected Publications

  • Knobloch G, Colgan T, Wiens CN, Wang X, Schubert T, Hernando D, Sharma SD and Reeder SB. Relaxivity of Ferumoxytol at 1.5 T and 3.0 T. Investigative Radiology. 2018 May;53(5):257-263. DOI PMID
  • Schubert T, Motosugi U, Kinner S, Colgan TJ, Sharma SD, Hetzel S, Wells S, Campo CA and Reeder SB. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle. Journal of Magnetic Resonance Imaging. 2017 Nov;45(6):1617-1626. DOI PMID
  • Kinner S, Schubert TB, Said A, Mezrich JD and Reeder SB. Added value of gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications. European Radiology. 2017 Apr;27(10):4415-4425. DOI PMID
  • Bannas P, Bookwalter CA, Ziemlewicz T, Motosugi U, Munoz del Rio A, Potretzke TA, Nagle SK and Reeder SB. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases. European Radiology. 2017 Apr;27(1):32-40. DOI PMID